検索結果

研究開発の取り組み | 千寿製薬株式会社

R & D activities Product Development Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licens...

Supplement business | Business Activities | About Senju | SENJU Pharmaceutical

Senju Pharmaceutical, as a pioneer of ophthalmic drugs, has long engaged in developing prescription and OTC drugs to contribute to the health of all people. As our next mission, we have found a way to...

千寿製薬株式会社

Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Ey...

Ethical Products for Medical Professionals | Business Activities | About Senju | SENJU Pharmaceutical

se cooperation with clinicians, Senju Pharmaceutical has succeeded in developing uniquely effective and highly reliable ophthalmological products that have earned the confidence of the international m...

DS, et al. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. Retina. 2017;37(5):819-835. 2 Cheung, C.M.G., Ch...